Smart Discharges to Improve Post-discharge Health Outcomes in Children

NCT05730452 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11700

Last updated 2023-02-15

No results posted yet for this study

Summary

In Uganda, about 5% of children discharged after hospitalization for a serious infection will die in the weeks after returning home. Doctors and parents are often unaware of this period of vulnerability and are poorly equipped to identify or handle this critical situation. This project builds on past work to develop and evaluate models and technology to predict, before discharge, an individual child's risk of recurrent illness, as well as to provide additional post-discharge support to at-risk children. This study seeks to evaluate the effect of a novel "Smart Discharges" approach on childhood mortality and health seeking behaviour.

Conditions

Interventions

BEHAVIORAL

Risk-stratified discharge and post-discharge care

Interventional intensity is based on predicted risk. Predicted risk based on previously developed prediction algorithms. Low risk: receive discharge education and counselling only; Moderate risk: Discharge education and counselling + 1 post-discharge follow-up referral at day 7; High risk: Discharge education and counselling + 3 post-discharge follow-up referrals (D2, D7, D14); Very high risk: Discharge education and counselling + 3 post-discharge follow-up referrals (D2, D7, D14, D28)

Sponsors & Collaborators

  • Walimu

    collaborator OTHER
  • Mbarara University of Science and Technology

    collaborator OTHER
  • Grand Challenges Canada

    collaborator OTHER
  • Thrasher Research Fund

    collaborator OTHER
  • British Columbia Childrens Hospital Foundation

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Matthew O Wiens, PharmD, PhD · University of British Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
0 Days
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-16
Primary Completion
2024-01-31
Completion
2024-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05730452 on ClinicalTrials.gov